awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48109284-71294337-1FAA-40F7-B0DA-253C8318428E
Q48109284-71294337-1FAA-40F7-B0DA-253C8318428E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48109284-71294337-1FAA-40F7-B0DA-253C8318428E
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.
P2860
Q48109284-71294337-1FAA-40F7-B0DA-253C8318428E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48109284-71294337-1FAA-40F7-B0DA-253C8318428E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b7cb61de7553ee9966e59118dcc24aa74c3c217
P2860
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis.